Spain for the Oncopaz Cooperative Group

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

J. Feliu, A. Pèlegrin, M. González-Barón, 2005, British Journal of Cancer.